GI
CGON icon

GAMMA Investing’s CG Oncology CGON Stock Holding History

GAMMA Investing’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.9K Buy
731
+70
+11% +$4.58K ﹤0.01% 2271
2026
Q1 		$44.7K Buy
661
+150
+29% +$8.5K ﹤0.01% 2250
2025
Q4 		$21.2K Buy
511
+20
+4% +$828 ﹤0.01% 2579
2025
Q3 		$19.8K Sell
491
-40
-8% -$1.16K ﹤0.01% 2520
2025
Q2 		$13.8K Buy
531
+437
+465% +$10.5K ﹤0.01% 2650
2025
Q1 		$2.3K Sell
94
-106
-53% -$2.98K ﹤0.01% 3372
2024
Q4 		$5.74K Buy
200
+94
+89% +$3.22K ﹤0.01% 2859
2024
Q3 		$4K Buy
+106
New +$3.72K ﹤0.01% 2833

Other funds holding CGON

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EC
Eleva Capital Paris, France $343M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return